Share |
Press Releases 2013
November 28, 2013 at 6:00 pm

Verisante Technology, Inc. Announces 2013 Third Quarter Results and Plans for Direct Distribution in Canada


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has released its financial results for the third quarter ended September 30, 2013. Highlights of the quarter include: Highest quarterly revenues...

Full story
November 8, 2013 at 6:00 pm

Verisante Technology, Inc. Closes Prospectus Offering


TO BE FEATURED ON BUSINESS TELEVISION (BTV) VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced closing of its previously announced commercially reasonably efforts  public offering of units (“Units”) pursuant to a short form base...

Full story
October 11, 2013 at 9:20 pm

Verisante Technology, Inc. Files Prospectus Supplement


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that it has filed a prospectus supplement (the “Prospectus Supplement”) dated October 11, 2013 to its final short form base shelf prospectus dated September 30, 2013. ...

Full story
September 13, 2013 at 11:00 pm

Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has filed a preliminary short form base shelf prospectus ("Prospectus") with the securities regulatory authorities in the provinces British Columbia, Ontario and Alberta. ...

Full story
September 10, 2013 at 2:00 pm

Verisante Technology, Inc. Announces Completion of Prototype of Multispectral Imaging System for Skin Cancer


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has completed the second phase prototype of a rapid Multispectral Imaging (“MSI”) System for skin cancer detection. The MSI device is intended to...

Full story
August 30, 2013 at 1:00 pm

Verisante Technology, Inc. Announces 2013 Second Quarter Results and Reports on Progress with Core Device


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has released its financial results for the second quarter ended June 30, 2013 . Highlights of the quarter include: Continued revenues...

Full story
August 14, 2013 at 5:00 pm

SeeThruEquity Initiates Coverage on Verisante Technology, Inc.


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that SeeThruEquity, an investment research firm, has initiated coverage on the Company. SeeThruEquity provides research on companies with market capitalizations below $1 billion. The report on...

Full story
August 7, 2013 at 2:00 pm

Verisante Technology, Inc. Announces Study on Nasopharnygeal Cancer in China


VERISANTE CORE™ STUDY FOR LUNG CANCER HAS CONCLUDED AND COLON CANCER STUDY IS SUCCESSFULLY UNDERWAY   VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer...

Full story
August 2, 2013 at 3:30 pm

Verisante: Unaware of Any Material Change


Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer imaging technology, wishes to confirm that it is unaware of any material change in the Company's operations that would account for the recent market activity.   About Verisante Technology, Inc. Verisante is a...

Full story
July 17, 2013 at 5:00 pm

Verisante Technology, Inc. Exhibits at the World Congress of Melanoma


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF,) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it is exhibiting at the 8th World Congress of Melanoma in Hamburg, Germany on July 17-20. Laserwelt, the Company’s exclusive distributor for Verisante Aura™ in Germany,...

Full story
June 7, 2013 at 7:00 pm

Verisante Announces Exclusive Distribution Agreement with Frontière Médicale EUROPE LLC for the UK and Ireland


SKIN CANCER RATES RISING DRAMATICALLY ACROSS THE UK AND IRELAND  VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has entered into an exclusive agreement with Frontière Médicale EUROPE LLC. (“Frontmed”) to...

Full story
June 4, 2013 at 4:00 pm

Verisante Technology, Inc. Announces 2013 First Quarter Results and Reports on Successful Launch of Aura in Canada and Europe


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has released its financial results for the first quarter ended March 31, 2013 . Highlights of the quarter include First revenues...

Full story
May 28, 2013 at 1:26 pm

Unaware of Any Material Change


Vancouver, Canada: Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer imaging technology, wishes to confirm that it is unaware of any material change in the Company's operations that would account for the recent market activity.   About Verisante Technology, Inc. Verisante...

Full story
May 17, 2013 at 7:57 pm

Verisante Completes Private Placement


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), announced today that it has closed its brokered private placement of 2,357,500 units (“Units”) at a price of $0.40 per Unit for gross proceeds of $943,000 led by sole agent Raymond James Ltd. (the...

Full story
May 10, 2013 at 6:15 pm

Verisante Technology, Inc. Private Placement Terms Amended


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the brokered private placement announced on February 27, 2013 through Agent Raymond James (the “Offering”) has been amended and shall be closed shortly with existing...

Full story
April 26, 2013 at 3:00 pm

Verisante Aura is Named a 2013 Bronze Edison Award Winner


REVOLUTIONARY SKIN CANCER DETECTOR HONOURED IN CHICAGO VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Verisante Aura™, a non-invasive skin cancer detection device, was voted a Bronze Edison Award winner for...

Full story
April 16, 2013 at 2:30 pm

Verisante Announces Official Launch of Aura in Canada, Provides Operational Update


REVOLUTIONARY SKIN CANCER DETECTOR NOW AVAILABLE TO CANADIAN PATIENTS VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced that Clarion Medical Technologies Inc., the Company’s exclusive distributor for Aura™ in Canada will be hosting an official...

Full story
March 20, 2013 at 6:51 pm

Verisante Announces Official Launch of Aura in Germany


EXCLUSIVE DISTRIBUTOR, LASERWELT, EXHIBITS THE REVOLUTIONARY SKIN CANCER DETECTOR AT MAJOR DERMATOLOGY CONFERENCE IN FRANKENTHAL, GERMANY VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced that Laserwelt, the Company’s exclusive distributor for Aura™ in Germany,...

Full story
February 27, 2013 at 8:15 pm

Verisante Technology, Inc. Announces Brokered Private Placements


  NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company intends to complete two separate and independent...

Full story
February 19, 2013 at 5:30 pm

Verisante Technology, Inc. Announces Exclusive Distribution Agreement with Pacifica Handels AG for Switzerland


  SWITZERLAND HAS THIRD HIGHEST SKIN CANCER RATE IN THE WORLD VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has entered into an exclusive agreement with Pacifica Handels...

Full story
February 13, 2013 at 1:30 pm

Verisante Named Edison Awards Finalist


AURA TO BE RECOGNIZED AT EDISON AWARDS GALA ON APRIL 25, 2013 IN CHICAGO VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Verisante Aura™, a revolutionary skin cancer detection device,...

Full story
February 8, 2013 at 2:00 pm

Verisante Technology, Inc. Retains Hamza Thindal Capital Corp. for Investor Relations


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that it has retained Hamza Thindal Capital Corp. (the “Firm” or “Hamza Thindal”) for investor relations to help broaden investor awareness via the Firm’s...

Full story
February 7, 2013 at 6:00 pm

Verisante Wins Prism Award at SPIE Photonics West Gala


PRESTIGIOUS HONOUR COMES AS THE COMPANY BEGINS TO PLACE THE INNOVATIVE SKIN CANCER DETECTOR AT CLINICS ACROSS CANADA AND EUROPE VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company...

Full story
January 30, 2013 at 2:30 pm

Verisante Technology, Inc. Announces First Sales of Aura, a Revolutionary Medical Device for the Detection of Skin Cancer


HIGHLY ANTICIPATED INITIAL PRODUCTION RUN OF 10 AURA DEVICES TO BE PLACED IN CANADA AND EUROPE VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has received purchase orders for...

Full story
January 29, 2013 at 10:56 pm

Verisante Technology, Inc. Retains Crescendo Communications for Investor Relations


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced that it has retained Crescendo Communications, LLC ("Crescendo") to help increase investor awareness throughout North America. "We are pleased and excited to start...

Full story
January 17, 2013 at 7:25 pm

Verisante Technology, Inc. Announces Expansion of Exclusive Distribution Agreement with bo pharma BV into Nordic Countries


INNOVATIVE SKIN CANCER DEVICE WILL BE AVAILABLE IN SWEDEN, NORWAY, DENMARK, FINLAND AND ICELAND VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has amended its exclusive agreement with bo...

Full story
January 10, 2013 at 2:00 pm

Verisante Announces Exclusive Distribution Agreement with Laserwelt Berlin for Germany, Austria and Liechtenstein


SKIN CANCER INCIDENCE IN GERMANY IS 20 PER CENT HIGHER 
THAN THE REST OF EUROPE VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has entered into an exclusive agreement...

Full story

  Back to top